A news article on temporary guidelines from The Food and Drug Administration (FDA) for remote ophthalmic assessment and monitoring devices during the coronavirus crisis. The guidance is covers diagnostic devices such as visual acuity charts, visual field devices and general-use ophthalmic cameras and tonometers.
Don’t Miss New Content - Register to Receive Updates
Latest Content in this Category
- DOL Issues New FFCRA Regulations To Replace Regulations Invalidated by New York Federal Court Last Month
- OSHA Publishes New Guidance on Use of Cloth Face Coverings and Heat Illness Prevention
- Guidance on Preparing Workplaces for COVID-19
- Government Response to Coronavirus
- The CDC’s Homepage for Coronavirus Resources
- Businesses and Workplaces: Plan, Prepare and Respond
- Discretion in Enforcement: Considering an Employer’s Good Faith Efforts During COVID-19 Pandemic
- Update: Paycheck Protection Program and Health Care Enhancement Act Increases Funds Available to Hospital and Health Care Providers
- FDA Issues Guidelines for Remote Ophthalmic Testing and Monitoring